Skip to main content
. 2023 Aug 29;38(2):86–93. doi: 10.15605/jafes.038.02.19

Table 6.

Exploratory results on the association of patient characteristics with malignancy

Characteristics Crude OR (95% CI) P
Age (in years) 1.00 (0.96-1.05) 0.967
Sex
 Female Ref Ref
 Male 0.51 (0.12-2.11) 0.351
Past medical history
Thyroid disease
 Without Ref Ref
 With 1.72 (0.07-44.10) 0.743
Family history: Thyroid dysfunction
 No Ref Ref
 Yes 0.51 (0.12-2.11) 0.351
Family history: Thyroid malignancy
 No Ref Ref
 Yes 1.78 (0.26-12.24) 0.557
Smoking status
 No Ref Ref
 Yes 0.53 (0.09-3.35) 0.504
Alcohol consumption
 No Ref Ref
 Yes 1.26 (0.31-5.07) 0.746
Presence of obstructive symptoms
 No Ref Ref
 Yes 0.77 (0.14-4.27) 0.764
Thyroid medications
 No Ref Ref
 Yes 0.78 (0.20-2.96) 0.712
Sonographic pattern
 Very low/low Ref Ref
 Intermediate 0.96 (0.28-3.33) 0.949
 High 1.83 (0.49-6.76) 0.368
Size of thyroid nodule
 ≥1 cm Ref Ref
 <1 cm 2.24 (0.34-14.81) 0.401
Vascularity
 Non-vascular Ref Ref
 Vascular 1.02 (0.20-5.26) 0.984
Calcification
 Negative Ref Ref
 Positive 1.63 (0.47-5.64) 0.443
Echogenicity
 Isoechoic Ref Ref
 Hypoechoic 1.17 (0.40-3.41) 0.771
 Hyperechoic 0.60 (0.06-6.54) 0.675
First FNAB
 Cytologic atypia Ref Ref
 Architectural atypia 0.11 (0.01-1.10) 0.061
 Both cytologic and architectural atypia 0.90 (0.23-3.52) 0.876
Second FNAB
 Cytologic atypia Ref Ref
 Architectural atypia 0.27 (0.04-1.68) 0.161
 Both cytologic and architectural atypia 1.63 (0.44-6.07) 0.470